Phase 2 data show long-term efficacy for Risankizumab in Crohn’s Disease. https://t.co/RUKiw3fetQ @SiobhanIBD… https://t.co/SJDseUHkPo
Phase 2 data show long-term efficacy for Risankizumab in Crohn’s Disease. https://t.co/RUKiw3fetQ @SiobhanIBD… https://t.co/SJDseUHkPo